Magellan Health Reports Second Quarter 2018 Financial Results

Go back to Magellan Health Reports Second Quarter 2018 Financial Results

Magellan Health (MGLN) Misses Q2 EPS by 31c, Miss on Revenues; Lowers FY18 EPS/Revenue Outlook

July 27, 2018 6:35 AM EDT

Magellan Health (NASDAQ: MGLN) reported Q2 EPS of $0.92, $0.31 worse than the analyst estimate of $1.23. Revenue for the quarter came in at $1.81 billion versus the consensus estimate of $1.88 billion.

Highlights Include:

Net revenue increased 27.6 percent over the second quarter of 2017 to $1.8 billion.Net income increased 146.4 percent over the second quarter of 2017 to $13.6 million.Segment profit increased 25.2 percent over the second quarter of 2017 to $68.0 million.Adjusted net income increased 65.2 percent from the second quarter of 2017 to $23.3 million.Unrestricted cash and investments were $244.4 million as of June 30, 2018. Approximately $115.8... More